Siloam International Hospitals Tbk PT
IDX:SILO
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
2 020
3 750
|
| Price Target |
|
We'll email you a reminder when the closing price reaches IDR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Siloam International Hospitals Tbk PT
Siloam International Hospitals Tbk PT
Net Income (Common)
Siloam International Hospitals Tbk PT
Net Income (Common) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Siloam International Hospitals Tbk PT
IDX:SILO
|
Net Income (Common)
Rp987.3B
|
CAGR 3-Years
12%
|
CAGR 5-Years
77%
|
CAGR 10-Years
28%
|
|
|
Medikaloka Hermina Tbk PT
IDX:HEAL
|
Net Income (Common)
Rp556.7B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
|
|
Metro Healthcare Indonesia Tbk PT
IDX:CARE
|
Net Income (Common)
-Rp110.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-32%
|
CAGR 10-Years
N/A
|
|
|
S
|
Sejahteraraya Anugrahjaya Tbk PT
IDX:SRAJ
|
Net Income (Common)
Rp9.4B
|
CAGR 3-Years
-67%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Mitra Keluarga Karyasehat Tbk PT
IDX:MIKA
|
Net Income (Common)
Rp1.1T
|
CAGR 3-Years
-3%
|
CAGR 5-Years
11%
|
CAGR 10-Years
9%
|
|
|
F
|
Famon Awal Bros Sedaya Tbk PT
IDX:PRAY
|
Net Income (Common)
Rp217B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Siloam International Hospitals Tbk PT
Glance View
Siloam International Hospitals Tbk PT, a pivotal entity in Indonesia's healthcare landscape, weaves its success through a network of over 40 hospitals strategically spread across the archipelago. Born from the vision of the Lippo Group, Siloam has capitalized on the growing demand for quality healthcare to become one of the largest private hospital operators in the country. As the Indonesian middle class expands, so too does its emphasis on healthcare quality and accessibility, a trend Siloam has efficiently tapped into. The company’s robust integration of healthcare services, ranging from inpatient and outpatient care to diagnostics and medical laboratories, allows it to offer comprehensive solutions that cater to various medical needs. Siloam's business model thrives on aligning itself with Indonesia's burgeoning healthcare requirements by focusing on revenue streams that span from essential healthcare services to specialized medical procedures. This diverse service range facilitates a steady flow of patients, ensuring a balanced mix of routine care and higher-margin specialized treatments. Furthermore, by leveraging cutting-edge technology and forming synergistic ties with medical professionals and institutions, Siloam enhances both its service quality and operational efficiency. As it navigates the intricate healthcare market, Siloam's sustained growth reflects its adept navigation of regulatory landscapes and its commitment to accessible, high-quality medical care for Indonesians, ultimately driving its profitability and expanding its footprint across the nation’s healthcare sector.
See Also
What is Siloam International Hospitals Tbk PT's Net Income (Common)?
Net Income (Common)
987.3B
IDR
Based on the financial report for Sep 30, 2024, Siloam International Hospitals Tbk PT's Net Income (Common) amounts to 987.3B IDR.
What is Siloam International Hospitals Tbk PT's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
28%
Over the last year, the Net Income (Common) growth was -11%. The average annual Net Income (Common) growth rates for Siloam International Hospitals Tbk PT have been 12% over the past three years , 77% over the past five years , and 28% over the past ten years .
You don't have any saved screeners yet